Cytosorbents (CTSO) Notes Payables (2011 - 2014)

Cytosorbents has reported Notes Payables for 4 years, with the latest figure at $709338.0 in Q2 2014.

• For the quarter ending Q2 2014, Notes Payables fell 22.23% year-over-year to $709338.0; the trailing twelve-month figure through Jun 2014 stood at $709338.0 (down 22.23% YoY), and the FY2013 full-year result was $1.6 million, up 77.53% from the prior year.
• Notes Payables for Q2 2014 stood at $709338.0, down from $1.7 million in the prior quarter.
• The five-year high for Notes Payables was $1.7 million in Q1 2014, with the low at $238015.0 in Q3 2011.
• Historically, Notes Payables has averaged $1.0 million across 4 years, with a median of $973379.0 in 2012.
• Annual changes were most pronounced in 2012 — Notes Payables surged 308.96% — and 2013, when it dropped 23.05%.
• Cytosorbents' Notes Payables stood at $294323.0 in 2011, then jumped by 214.7% to $926225.0 in 2012, then surged by 77.53% to $1.6 million in 2013, then slumped by 56.86% to $709338.0 in 2014.
• The last three Notes Payables figures came in at $709338.0 (Q2 2014), $1.7 million (Q1 2014), and $1.6 million (Q4 2013), per Business Quant data.